Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1992-07-20
1994-11-08
Hill, Jr., Robert J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
424 852, 530351, 530399, A61K 3700
Patent
active
053627164
ABSTRACT:
The present invention relates to a complex comprising hepatocyte growth factor (HGF) and met proto-oncogene protein. The present invention also relates to methods for detecting the presence of HGF ligand, met proto-oncogene receptor and methods for isolating either the ligand or receptor or complex comprising both. The present invention further relates to methods of diagnostic proliferative disorders and diseases such as hepatitis or hepatocarcinogenesis by detecting these ligand-receptor pairs.
REFERENCES:
patent: 5004805 (1991-04-01), Gohda et al.
patent: 5227158 (1993-07-01), Jardieu
Y. Daikuhara et al., "Monoclonal Antibody", Patent Abstracts of Japan: Unexamined Applications, 13(174): p. 19 C 589, Abstract 64-3 199 (Apr. 25, 1989).
Y. Daikuhara et al., "Monoclonal Antibody", Patent Abstracts of Japan: Unexamined Applications, 13(208): p. 120 C 596, Abstract 1-27491 (May 16, 1989).
Hunter et al., "Preparation of Iodine--131 Labelled Human Growth Hormone of High Specific Activity," Nature, vol. 194, No. 4827, pp. 495-496 (May 1962).
Laemmli, "Cleavage of Structural Proteins During the Assembly of the Head of Bacteriophage T4," Nature, vol. 227, pp. 680-685 (Aug. 1970).
Stanley et al., "Standardized Bioassay for Bone Marrow Colony Stimulating Factor in Human Urine: Levels in Normal Man," J. Lab Clin. Med. vol. 79, pp. 657-668 (Apr. 1972).
Kohler et al., "Continuous Cultures of Fused Cells Secreting Antibody of Predefined Specificity," Nature, vol. 256, pp. 495-497 (1975).
Holmes et al., "Correlation of Cell-Surface Phenotype with the Establishment of Interleukin 3-Dependent Cell Lines From Wild-Mouse Murine Leukemia Virus-Induced Neoplasms," Proc. Natl. Acad. Sci. USA, vol. 82, pp. 6687-6691 (Oct. 1985).
Stoker et al., "Scatter Factor is a Fibroblast-Derived Modulator of Epithelial Cell Mobility," Nature, vol. 327, pp. 239-242 (May 1987).
Park et al., "Sequence of MET Protooncogene cDNA has Features Characteristic of the Tyrosine Kinase Family of Growth-Factor Receptors," Proc. Natl. Acad. Sci. USA, vol. 84, pp. 6379-6383 (Sep. 1987).
Ikebuchi et al., "Interleukin 6 Enhancement of Interleukin 3-Dependent Proliferation of Multipotential Hemopoietic Progenitors," Proc. Natl. Acad. Sci. USA, vol. 84, pp. 9035-9039 (Dec. 1987).
Gonzatti-Haces et al., "Characterization of the TPR-MET Oncogene p65 and the MET Protooncogene p140 Protein-Tyrosine Kinases," Proc. Natl. Acad. Sci. USA, vol. 85, pp. 21-25 (Jan. 1988).
Gohda et al., "Purification and Partial Characterization of Hepatocyte Growth Factor from Plasma of a Patient with Fulminant Hepatic Failure," J. Clin. Invest., vol. 81, pp. 414-419 (Feb. 1988).
Shoelson et al., "Tryptic Acitvation of the Insulin Receptor," The Journal of Biological Chemistry, vol. 263, No. 10, pp. 4852-4860 (Apr. 1988).
Leary et al., "Synergism Between Interleukin-6 and Interleukin-3 in Supporting Proliferation of Human Hematopoietic Stem Cells: Comparison With Interleukin-1a," Blood, vol. 71, No. 6, pp. 1759-1763 (Jun. 1988).
Chan et al., "Characterization of the Mouse MET Proto-Oncogene," Oncogene, vol. 2, pp.593-599 (1988).
Tempest et al., "Structure of the MET Protein and Variation of MET Protein Kinase Activity Among Human Tumour Cell Lines," Br. J. Cancer, vol. 58, pp. 3-7 (1988).
Hara et al., "Bipotential Murine Hemopoietic Cell Line (NFS-60) That Is Responsive to IL-3, GM-CSF, G-CSF, and Erythropoietin," Exp. Hematol., vol. 16, pp. 256-261 (1988).
Stern et al., "EGF-Stimulated Tyrosine Phosphorylation of p185.sup.neu : A Potential Model for Receptor Interactions," EMBO Journal, vol. 7, No. 4, pp. 995-1001 (1988).
King et al., "EGF Binding to its Receptor Triggers a Rapid Tyrosine Phosphorylation of the erbB-2 Protein in the Mammary Tumor Cell Line SK-BR-3," EMBO Journal, vol. 7, No. 6, pp. 1647-1651 (1988).
Zarnegar et al., "Purification and Biological Characterization of Human Hepatopoietin A, a Polypeptide Growth Factor for Hepatocytes," Cancer Research, vol. 49, pp. 3314-3320 (Jun. 1989).
Gherardi et al., "Purification of Scatter Factor, A Fibroblast-Derived Basic Protein that Modulates Epithelial Interactions and Movement," Proc. Natl. Acad. Sci. USA, vol. 86, pp. 5844-5848 (Aug. 1989).
Miyazawa et al., "Molecular Cloning and Sequence Analysis of cDNA for Human Hepatocyte Growth Factor," Biochemical and Biophysical Research Communications, vol. 163, No. 2, pp. 967-973 (Sep. 1989).
Nakamura et al., "Molecular Cloning and Expression of Human Hepatocyte Growth Factor," Nature, vol. 342, pp. 440-443 (Nov. 1989).
Kinoashita et al., "Marked Increase of HGF mNRA in Non-Parenchymal Liver Cells of Rats Treated with Hepatotoxins," Biochem. and Biophys. Res. Communications, vol. 165, No. 3, pp. 1229-1234 (Dec. 1989).
Giordano et al., "Biosynthesis of the Protein Encoded by the C-MET Proto-Oncogene," Oncogene, vol. 4, pp. 1383-1388 (1989).
Iyer et al., "Structure, Tissue-Specific Expression, and Transforming Activity of the Mouse met Protooncogene," Cell Growth & Differentiation, vol. 1, pp. 87-95 (1990).
Keller et al., "Transforming Growth Factor .beta. Directly Regulates Primitive Murine Hematopoietic Cell Proliferation," Blood, vol. 75, No. 3, pp. 596-602 (Feb. 1990).
Zarnegar et al., "Tissue Distribution of Hepatopoietin-A: A Heparin-Binding Polypeptide Growth Factor for Hepatocytes," Proc. Natl. Acad. Sci. USA, vol. 87, pp. 1252-1256 (Feb. 1990).
Tashiro et al., "Deduced Primary Structure of Rat Hepatocyte Growth Factor and Expression of the mRNA in Rat Tissues," Proc. Natl. Acad. Sci. USA, vol. 87, pp. 3200-3204 (Apr. 1990).
Bottaro et al., "Characterization of the Receptor for Keratinocyte Growth Factor," The Journal of Biological Chemistry, vol. 265, No. 22, pp. 12767-12770 (Aug. 1990).
Weidner et al., "Scatter Factor: Molecular Characteristics and Effect on the Invasiveness of Epithelial Cells," The Journal of Cell Biology, vol. 111, pp. 2097-2108 (Nov. 1990).
Kuma et al., "Effect of Human Recombinant Interleukin-6 on the Proliferation of Mouse Hepatocytes in the Primary Culture," Immunobiol. vol. 180, pp. 235-242 (1990).
Roldan et al., "Cloning and Expression of the Receptor for Human Urokinase Plasminogen Activator, a Central Molecule in Cell Surface, Plasmin Dependent Proteolysis," EMBO Journal, vol. 9, pp. 467-474 (1990).
Rubin et al., "A Broad-Spectrum Human Lung Fibroblast-Derived Mitogen is a Variant of Hepatocyte Growth Factor," Proc. Natl. Acad. Sci. USA, vol. 88, pp. 415-419 (Jan. 1991).
Gherardi et al., "Hepatocyte Growth Factor-Scatter Factor: Mitogen, Motogen, and Met," Cancer Cells, vol. 3, No. 6, pp. 227-232 (Jun. 1991).
Rodrigues et al., "Alternative Splicing Generates Isoforms of the met Receptor Tyrosine Kinase Which Undergo Differential Processing," Molecular and Cellular Biology, vol. 11, No. 6, pp. 2962-2970 (Jun. 1991).
Weidner et al., "Evidence for the Identity of Human Scatter Factor and Human Hepatocyte Growth Factor," Proc. Natl. Acad. Sci. USA, vol. 88, pp. 7001-7005 (Aug. 1991).
Kmiecik Thomas E.
Vande Woude George F.
Hill Jr. Robert J.
Teng Sally P.
The United States of America as represented by the Department of
LandOfFree
Methods for stimulating hematopoietic progenitors using hepatocy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for stimulating hematopoietic progenitors using hepatocy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for stimulating hematopoietic progenitors using hepatocy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1782552